|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.76 USD | +1.50% |
|
+1.64% | +46.89% |
| 11-14 | Truist Raises Price Target on Guardian Pharmacy Services to $34 From $30, Keeps Buy Rating | MT |
| 11-11 | Top Midday Gainers | MT |
| Capitalization | 1.88B 1.62B 1.52B 1.41B 2.61B 170B 2.84B 17.75B 6.85B 80.1B 7.07B 6.92B 293B | P/E ratio 2025 * |
44.2x | P/E ratio 2026 * | 33.3x |
|---|---|---|---|---|---|
| Enterprise value | 1.88B 1.62B 1.52B 1.41B 2.61B 170B 2.84B 17.75B 6.85B 80.1B 7.07B 6.92B 293B | EV / Sales 2025 * |
1.31x | EV / Sales 2026 * | 1.3x |
| Free-Float |
99.04% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Guardian Pharmacy Services, Inc.
More recommendations
More press releases
| 1 day | +1.50% | ||
| 1 week | +1.64% | ||
| Current month | +1.64% | ||
| 1 month | +4.46% | ||
| 3 months | +5.49% | ||
| 6 months | +44.12% | ||
| Current year | +46.89% |
| 1 week | 28.62 |  | 29.9 |
| 1 month | 27.38 | | 37.43 |
| Current year | 17.78 | | 37.43 |
| 1 year | 17.78 | | 37.43 |
| 3 years | 14.16 | | 37.43 |
| 5 years | 14.16 | | 37.43 |
| 10 years | 14.16 | | 37.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kendall Forbes
COO | Chief Operating Officer | 69 | 30/06/2004 |
David Morris
DFI | Director of Finance/CFO | 62 | 20/07/2003 |
Fred Burke
CEO | Chief Executive Officer | 76 | 20/07/2003 |
| Director | Title | Age | Since |
|---|---|---|---|
William Bindley
CHM | Chairman | 84 | 20/07/2003 |
Fred Burke
BRD | Director/Board Member | 76 | 20/07/2003 |
David Morris
BRD | Director/Board Member | 62 | 20/07/2003 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.50% | +1.64% | +19.04% | - | 1.88B | |
| +0.08% | -1.47% | +107.94% | -27.25% | 24.76B | |
| -0.91% | -2.33% | +50.69% | -36.23% | 11.3B | |
| -0.16% | -2.01% | +24.79% | +41.36% | 7.25B | |
| -0.01% | -0.98% | -13.72% | +18.81% | 4.76B | |
| -0.09% | +3.09% | -0.98% | -38.74% | 4B | |
| +2.59% | +3.78% | -15.24% | -40.86% | 3.47B | |
| -0.50% | +0.91% | +13.93% | -50.78% | 2.87B | |
| 0.00% | -1.61% | -11.12% | +73.01% | 2.87B | |
| +1.12% | +0.83% | -6.77% | +14.82% | 1.77B | |
| Average | +0.36% | +0.08% | +16.86% | -5.09% | 6.49B | |
| Weighted average by Cap. | +0.04% | -0.90% | +51.35% | -14.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.44B 1.24B 1.16B 1.08B 2B 130B 2.17B 13.57B 5.24B 61.24B 5.41B 5.29B 224B | 1.45B 1.25B 1.17B 1.09B 2.01B 131B 2.19B 13.68B 5.28B 61.73B 5.45B 5.33B 226B |
| Net income | 43.87M 37.71M 35.33M 32.93M 60.82M 3.95B 66.16M 413M 160M 1.86B 165M 161M 6.82B | 55.72M 47.9M 44.87M 41.82M 77.25M 5.02B 84.03M 525M 203M 2.37B 209M 205M 8.66B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
3,400
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 29.76 $ | +1.50% | 255,052 |
| 04/12/25 | 29.32 $ | +0.21% | 189,441 |
| 03/12/25 | 29.26 $ | -0.07% | 222,521 |
| 02/12/25 | 29.28 $ | +1.77% | 260,695 |
| 01/12/25 | 28.77 $ | -1.74% | 247,967 |
Delayed Quote Nyse, December 05, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
29.76USD
Average target price
34.00USD
Spread / Average Target
+14.25%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GRDN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition